ARTICLE SUMMARY:
J&J’s recent blockbuster deal for Auris is really just the latest in a series of moves the company has made recently in positioning the diversified medtech giant in the exploding field of robotically-enabled surgery. From Verb, its joint venture with Verily, to Orthotaxy to, now, Auris, J&J is developing and advancing what the company calls “a comprehensive digital surgery experience.”
The announcement this past February that Johnson & Johnson had acquired robotic start-up Auris, founded by Fred Moll, a pioneer in the field, came as an almost audible blast in the medtech industry.
